| Lara Thompson, MD | |
|
418 Cloverleaf Rd, Elizabethtown, PA 17022-9320 | |
| (717) 653-1467 | |
| (717) 653-1001 |
| Full Name | Lara Thompson |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 17 Years |
| Location | 418 Cloverleaf Rd, Elizabethtown, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386852895 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | MD438956 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Penn Medicine Home Health Lancaster General Health | Lancaster, PA | Home health agency |
| Lancaster General Hospital | Lancaster, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Lancaster General Medical Group | 0941103683 | 463 |
News Archive
Results revealed today at The International Liver Congress 2015 demonstrate current treatment and prevention programmes need to be scaled up in order to make elimination of hepatitis B virus (HBV) possible.
AbbVie, a research-based global biopharmaceutical company, today announced positive results from U-ACHIEVE, an ongoing Phase 2b/3 dose-ranging study evaluating upadacitinib, an investigational JAK1-selective inhibitor, for induction and maintenance therapy in adult patients with moderately to severely active ulcerative colitis.
Ventrus Biosciences Inc., a pharmaceutical company focused on developing and commercializing gastrointestinal products, today announced that it closed its previously announced public offering of 2,900,000 shares of common stock.
It is estimated that in 2000, more than 359,000 persons were living with a diagnosis of a primary brain tumor in the United States. In 2005, it is estimated that nearly 12,800 deaths will be associated with malignant tumors of the brain and other parts of the central nervous system. Brain tumors are the leading cause of cancer-related deaths in children age 19 and younger.
› Verified 8 days ago
| Entity Name | Lancaster General Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952392383 PECOS PAC ID: 0941103683 Enrollment ID: O20040309000916 |
News Archive
Results revealed today at The International Liver Congress 2015 demonstrate current treatment and prevention programmes need to be scaled up in order to make elimination of hepatitis B virus (HBV) possible.
AbbVie, a research-based global biopharmaceutical company, today announced positive results from U-ACHIEVE, an ongoing Phase 2b/3 dose-ranging study evaluating upadacitinib, an investigational JAK1-selective inhibitor, for induction and maintenance therapy in adult patients with moderately to severely active ulcerative colitis.
Ventrus Biosciences Inc., a pharmaceutical company focused on developing and commercializing gastrointestinal products, today announced that it closed its previously announced public offering of 2,900,000 shares of common stock.
It is estimated that in 2000, more than 359,000 persons were living with a diagnosis of a primary brain tumor in the United States. In 2005, it is estimated that nearly 12,800 deaths will be associated with malignant tumors of the brain and other parts of the central nervous system. Brain tumors are the leading cause of cancer-related deaths in children age 19 and younger.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Lara Thompson, MD 418 Cloverleaf Rd, Elizabethtown, PA 17022-9320 Ph: (717) 653-1467 | Lara Thompson, MD 418 Cloverleaf Rd, Elizabethtown, PA 17022-9320 Ph: (717) 653-1467 |
News Archive
Results revealed today at The International Liver Congress 2015 demonstrate current treatment and prevention programmes need to be scaled up in order to make elimination of hepatitis B virus (HBV) possible.
AbbVie, a research-based global biopharmaceutical company, today announced positive results from U-ACHIEVE, an ongoing Phase 2b/3 dose-ranging study evaluating upadacitinib, an investigational JAK1-selective inhibitor, for induction and maintenance therapy in adult patients with moderately to severely active ulcerative colitis.
Ventrus Biosciences Inc., a pharmaceutical company focused on developing and commercializing gastrointestinal products, today announced that it closed its previously announced public offering of 2,900,000 shares of common stock.
It is estimated that in 2000, more than 359,000 persons were living with a diagnosis of a primary brain tumor in the United States. In 2005, it is estimated that nearly 12,800 deaths will be associated with malignant tumors of the brain and other parts of the central nervous system. Brain tumors are the leading cause of cancer-related deaths in children age 19 and younger.
› Verified 8 days ago
Neal S Harnly, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 418 Cloverleaf Rd, Elizabethtown, PA 17022 Phone: 717-653-1467 Fax: 717-653-1001 | |
Diana Tacelosky, M.D., PH.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 1 Continental Dr, Elizabethtown, PA 17022 Phone: 717-531-5164 Fax: 717-531-0646 | |
Sarah Anne Lombel, PA-C Family Medicine Medicare: Medicare Enrolled Practice Location: 1 Continental Dr, Elizabethtown, PA 17022 Phone: 717-361-0666 | |
John J Mast, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 418 Cloverleaf Rd, Elizabethtown, PA 17022 Phone: 717-653-1467 Fax: 717-653-1001 | |
Scott C Conley, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 418 Cloverleaf Rd, Elizabethtown, PA 17022 Phone: 717-653-1467 Fax: 717-653-1001 | |
Christopher Michael Washington, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 432 Cloverleaf Rd, Elizabethtown, PA 17022 Phone: 717-544-6350 | |
Eric L Esch, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 418 Cloverleaf Rd, Elizabethtown, PA 17022 Phone: 717-653-1467 Fax: 717-653-1001 |